SCHEMBL5262249

SCHEMBL5262249

CNc1nccc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N[C@]3(C)CCN(C)C3)c2)n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 15/20 0.71
KDR P35968 11/20 0.63
AURKA O14965 4/20 0.52
LCK P06239 3/20 0.52
ABL1 P00519 2/20 0.52
CSF1R P07333 2/20 0.52
SRC P12931 2/20 0.52
MAPK14 Q16539 2/20 0.52
EGFR P00533 1/20 0.52
NTRK1 P04629 1/20 0.52
INSR P06213 1/20 0.52
FES P07332 1/20 0.52
LYN P07948 1/20 0.52
RET P07949 1/20 0.52
IGF1R P08069 1/20 0.52
MET P08581 1/20 0.52
PDGFRB P09619 1/20 0.52
FGR P09769 1/20 0.52
AKT1 P31749 1/20 0.52
CSK P41240 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5257056 0.87 TEK (0.59) TEKKDRAURKALCKABL1
SCHEMBL1265206 0.85 TEK (0.89) TEKKDRAURKALCKABL1
SCHEMBL5259637 0.85 TEK (0.72) TEKKDRAURKALCKABL1
SCHEMBL1264957 0.83 TEK (0.99) TEKKDRAURKALCKABL1
SCHEMBL1264508 0.83 TEK (0.72) TEKKDRAURKALCKABL1
SCHEMBL2298956 0.83 TEK (1.00) TEKKDRAURKALCKABL1
SCHEMBL2293527 0.82 TEK (0.72) TEKKDRAURKALCKABL1
SCHEMBL5263165 0.82 TEK (0.68) TEKKDRAURKALCKABL1
SCHEMBL1265124 0.81 TEK (0.71) TEKKDRAURKALCKABL1
SCHEMBL1265065 0.81 TEK (0.71) TEKKDRAURKALCKABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751136-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2007-02-14 EP claimed
WO-2005113494-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2005-12-01 WO claimed